The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) shares rose 8.5% during trading on Monday . The company traded as high as $0.13 and last traded at $0.13. Approximately 774 shares were traded during trading, a decline of 95% from the average daily volume of 14,114 shares. The stock had previously closed at $0.12.
Oncology Institute Trading Up 8.5 %
The stock has a 50-day moving average of $0.12 and a 200 day moving average of $0.45.
Get
Oncology Institute alerts:
Insider Activity at Oncology Institute
In related news, major shareholder Havencrest Healthcare Partners sold 80,000 shares of the stock in a transaction that occurred on Wednesday, November 9th. The stock was sold at an average price of $3.09, for a total transaction of $247,200.00. Following the completion of the sale, the insider now directly owns 13,789,475 shares of the company's stock, valued at $42,609,477.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Oncology Institute news, major shareholder Havencrest Healthcare Partners sold 80,000 shares of the firm's stock in a transaction on Wednesday, November 9th. The stock was sold at an average price of $3.09, for a total value of $247,200.00. Following the completion of the sale, the insider now directly owns 13,789,475 shares of the company's stock, valued at $42,609,477.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Matthew P. Miller bought 73,684 shares of the firm's stock in a transaction on Friday, December 16th. The stock was purchased at an average cost of $0.95 per share, with a total value of $69,999.80. Following the completion of the transaction, the chief operating officer now directly owns 175,325 shares of the company's stock, valued at $166,558.75. The disclosure for this purchase can be found here. Over the last three months, insiders sold 461,315 shares of company stock valued at $1,132,465.
Hedge Funds Weigh In On Oncology Institute
A hedge fund recently raised its stake in Oncology Institute stock. Wolverine Asset Management LLC boosted its holdings in shares of The Oncology Institute, Inc. (NASDAQ:TOIIW – Get Rating) by 29.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 118,666 shares of the company's stock after buying an additional 26,700 shares during the period. Wolverine Asset Management LLC's holdings in Oncology Institute were worth $59,000 as of its most recent SEC filing.
About Oncology Institute
(Get Rating)
The Oncology Institute, Inc, an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants for cancer patients.
Recommended Stories
- Get a free copy of the StockNews.com research report on Oncology Institute (TOIIW)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.
